Sunday, December 4, 2022

Sonde Health Acquires NeuroLex Labs: Acquisition Brings Together Two of the Leading Forces in the Vocal Biomarker Space

Sonde Health, a leading vocal biomarker technology platform that detects health symptoms from a few seconds of voice, today announced it has acquired NeuroLex Laboratories, Inc., a leading voice-enabled survey and data acquisition platform. Jim Schwoebel, the chief executive officer of NeuroLex, will join Sonde’s leadership team as Vice President, Data and Research.

Sonde Health reports the acquisition brings together two of the leading forces in the vocal biomarker space. They will acquire NeuroLex’s popular web-enabled voice survey and analysis platform, as well as its rich dataset, which when combined with Sonde’s leading voice-based dataset, forms one of the world’s preeminent biobanks focused on vocal biomarkers. In addition, merging Sonde’s mobile and voice-assistant platforms with NeuroLex’s web-based capabilities will enable the delivery of voice-enabled heath detection and monitoring over any platform.

“At Sonde, we have unlocked voice as a new vital sign to enable secure, accessible, and non-intrusive monitoring of health. Incorporating NeuroLex’s impressive work in voice-based surveys and research moves us significantly forward in becoming the one-stop shop for health condition detection and monitoring through voice,” said David Liu, CEO of Sonde Health. “NeuroLex’s voice-based survey platform and biobank will accelerate our research and development, and our collection and analysis of high-quality voice data, bolstering all the products we provide to our customers.”

Sonde’s proprietary technology works by sensing and analyzing subtle changes in the voice due to changes in a person’s physiology. The company’s respiratory and depression health checks are available today.

“I am thrilled to bring Jim and his team on board,” continued Liu. “His experience in building NeuroLex, shared mission of using vocal biomarkers to move healthcare forward, and expertise in building large voice-based datasets and machine learning make Jim a tremendous addition to the Sonde team.”

“I’m beyond excited to join Sonde’s amazing team and mission,” said Jim Schwoebel. “We started NeuroLex to create a voice test to help screen for psychosis and related psychiatric conditions. Together with Sonde, we will expand beyond these conditions to transform the way both physical and mental health are detected and managed to positively impact lives.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
spot_img
spot_img

Our Sister Publication

Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy